Table 2.

Mean (±SEM) measures of locomotor (squares) and rearing activity in novelty test in Experiment 1.

Group	Squares						Rearings
	Session						Session
	I		II		III		I		II		III
	Phase 1	Phase 2	Phase 1	Phase 2	Phase 1	Phase 2	Phase 1	Phase 2	Phase 1	Phase 2	Phase 1	Phase 2
Saline	88.9 ± 6.5	61.5 ± 9.5	84.1 ± 5.6	72.3 ± 8.1	89.3 ± 9.5	66.0 ± 5.9	21.5 ± 1.5	14.3 ± 2.6	25.5 ± 2.2	19.1 ± 1.7	23.9 ± 3.2	18.1 ± 2.7
HI-6	89.8 ± 6.8	58.6 ± 7.9	90.1 ± 2.9	56.4 ± 5.8	86.0 ± 6.1	52.9 ± 6.0	21.9 ± 2.6	17.4 ± 3.0	24.8 ± 2.5	17.9 ± 1.6	22.9 ± 2.3	17.1 ± 1.7
Scopolamine	83.4 ± 5.9	42.3 ± 9.8	45.7 ± 9.3b	38.9 ± 8.6a	25.3 ± 9.8c	18.4 ± 8.9c	22.7 ± 2.8	19.3 ± 1.9	17.4 ± 2.4a	15.3 ± 1.9	18.5 ± 3.3	14.7 ± 1.8
Physostigmine	62.5 ± 6.1	22.3 ± 1.9b	60.9 ± 6.1a	53.8 ± 9.0	39.8 ± 9.1c	37.5 ± 6.7a	15.3 ± 1.8	9.6 ± 2.1	14.8 ± 3.0a	12.9 ± 3.1	8.1 ± 1.4c	11.3 ± 1.7
Levetiracetam	82.1 ± 7.7	63.9 ± 9.6	98.8 ± 7.6	68.0 ± 10.1	80.9 ± 4.6	60.9 ± 7.7	21.4 ± 1.5	14.8 ± 2.3	27.8 ± 1.9	20.1 ± 2.5	23.9 ± 3.1	20.8 ± 2.6
Procyclidine	68.2 ± 8.7	18.3 ± 3.1b	21.8 ± 3.7c	17.9 ± 4.4c	16.8 ± 3.8c	15.3 ± 3.3c	12.7 ± 2.3a	3.9 ± 1.9b	3.5 ± 1.8c	4.8 ± 2.1c	4.3 ± 2.1c	4.5 ± 2.2c

Doses and number of animals as in Table 1. Significantly different from the saline group:

^ap < 0.05,

^bp < 0.01,

^cp < 0.001.